Author： Kelly Emer Greene Catherine M McElvaney Noel G
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.2, 2008-02, pp. : 145-157
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeting the Root Cause of Cystic Fibrosis
Current Drug Targets, Vol. 16, Iss. 9, 2015-08 ,pp. :
Access to resources
Recommend
Targeting ENaC as a Molecular Suspect in Cystic Fibrosis
Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. :
Epigenetics in Cystic Fibrosis: Epigenetic Targeting of a Genetic Disease
Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. :
Neutrophil elastase inhibitors
By Groutas William C Dou Dengfeng Alliston Kevin R
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 3, 2011-03 ,pp. :
Inhibitors of human neutrophil elastase
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. :